Beneficial effect of the combination psilocybin-semaglutide in a murine model of Steatotic Liver Disease
No abstract is available for this record.
Bibliographic context
- Journal
- Digestive and Liver Disease
- Date
- 2025-01-31
- Source
- OpenAlex
- PubMed
- Unavailable
Authors
Martina ColognesiDaniela GabbiaA. SignorStefano ComaiAndrea MattareiGianfranco PasutFranco FolliLucia CentofantiS. La RosaG FinziM. PappagalloPaolo ManfrediSara De Martin
Watch author
Topics and keywords
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
Indexed papers citing this DOI
Related papers
C29-12 Psilocybin Treatment Could Improve Outcomes for Age-associated Lung DiseasesAmerican Journal of Respiratory and Critical Care Medicine · 2026-04-30‘Shroom’ for concern: a case of psychedelic mushroom-induced acute kidney injuryInternal Medicine Journal · 2025-12-31Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto RatsPsychedelic Medicine · 2025-12-15The Rise of Psilocybin Use in the United States: A Multisource Observational StudyAnnals of Internal Medicine · 2025-04-20Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialEClinicalMedicine · 2024-09-22PTSD Treatment: An Inquiry into the Promising Potential of PsilocybinJournal of Advances in Medicine and Medical Research · 2024-07-23Psilocybin poisoning from Psilocybe argentipes ingestionVisual Journal of Emergency Medicine · 2024-03-10Impact of Psilocybin on Peripheral Cytokine ProductionPsychedelic Medicine · 2024-02-27